Skip to Main Content

Paper Details

Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia: Updates From the LAST Study on Patient-Reported Outcomes and Biomarkers for Relapse.
JAMA Oncol
1
2021
Author NameAffiliation
Theodore P BraunKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
  • 1 - 2

Datasets

Release 1.2